当前位置: 首页 > 期刊 > 《中国现代医生》 > 2017年第3期
编号:13010870
ECP在慢性阻塞性肺疾病中的临床意义(3)
http://www.100md.com 2017年1月25日 《中国现代医生》 2017年第3期
     [9]Salturk C,Karakurt Z,Adiguzel N,et al. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit[J]. Int J Chron Obstruct Pulmin Dis,2015,8(10):1837-1846.

    [10]Global initiative for chronic obstructive lung disease. Global strategy for diagnosis,management,and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease,2016[EB/OL]. http://www.goldcopd.org.

    [11]王慧林,李清賢. 糖皮质激素治疗AECOPD有效的预测因素[J]. 临床肺科杂志,2013,18(5):888-889.

    [12]Bafadhel M,Mckenna S,Terry S,et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers[J]. Am J Respir Crit Care Med, 2011,184(6): 662-671.

    [13]Hasegawa K,Jr CC. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD[J]. Respirology,2015, 21(4):761-764.

    [14]董云龙. 糖皮质激素类药物的临床合理用药分析[J]. 今日健康,2016,15(12):147-149.

    [15]Muellerova H,Maselli DJ,Locantore N,et al. Hospitalized exacerbations of COPD:Risk factors and outcomes in the ECLIPSE cohort[J]. Chest,2015,147(4):999-1007.

    (收稿日期:2016-11-01), http://www.100md.com(王红)
上一页1 2 3